These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The value of screening for multiple arterio-venous malformations in hereditary hemorrhagic telangiectasia: a diagnostic study. Folz BJ; Wollstein AC; Alfke H; Dünne AA; Lippert BM; Görg K; Wagner HJ; Bien S; Werner JA Eur Arch Otorhinolaryngol; 2004 Oct; 261(9):509-16. PubMed ID: 14685882 [TBL] [Abstract][Full Text] [Related]
24. Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital. Karlsson T; Cherif H Ups J Med Sci; 2018 Sep; 123(3):153-157. PubMed ID: 30251589 [TBL] [Abstract][Full Text] [Related]
25. A Survey of Pulmonary Arteriovenous Malformation Screening, Management, and Follow-Up in Hereditary Hemorrhagic Telangiectasia Centers of Excellence. Chick JFB; Reddy SN; Pyeritz RE; Trerotola SO Cardiovasc Intervent Radiol; 2017 Jul; 40(7):1003-1009. PubMed ID: 28188364 [TBL] [Abstract][Full Text] [Related]
26. Hereditary hemorrhagic telangiectasia patients can tolerate anticoagulation. Edwards CP; Shehata N; Faughnan ME Ann Hematol; 2012 Dec; 91(12):1959-68. PubMed ID: 23053175 [TBL] [Abstract][Full Text] [Related]
27. Silent threat? A retrospective study of screening practices for pulmonary arteriovenous malformations in patients with hereditary haemorrhagic telangiectasia. Verkerk MM; Shovlin CL; Lund VJ Rhinology; 2012 Sep; 50(3):277-83. PubMed ID: 22888484 [TBL] [Abstract][Full Text] [Related]
28. Hereditary Hemorrhagic Telangiectasia (HHT) and Survival: The Importance of Systematic Screening and Treatment in HHT Centers of Excellence. de Gussem EM; Kroon S; Hosman AE; Kelder JC; Post MC; Snijder RJ; Mager JJ J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33172103 [TBL] [Abstract][Full Text] [Related]
29. Imaging of hereditary hemorrhagic telangiectasia. Carette MF; Nedelcu C; Tassart M; Grange JD; Wislez M; Khalil A Cardiovasc Intervent Radiol; 2009 Jul; 32(4):745-57. PubMed ID: 18972161 [TBL] [Abstract][Full Text] [Related]
30. Rendu-Osler-Weber disease: experience with 56 patients. Sabbà C; Pasculli G; Cirulli A; Gallitelli M; Virgilio G; Guastamacchia E; Resta F; Palasciano G Ann Ital Med Int; 2002; 17(3):173-9. PubMed ID: 12402665 [TBL] [Abstract][Full Text] [Related]
31. [Bevacizumab: a new success in hereditary hemorrhagic telangiectasia]. Bennesser Alaoui H; Lehraiki M; Hamaz S; El Attar N; Fakhreddine N; Serraj K Rev Med Interne; 2015 Sep; 36(9):623-5. PubMed ID: 25595875 [TBL] [Abstract][Full Text] [Related]
32. Lower Risk of Intracranial Arteriovenous Malformation Hemorrhage in Patients With Hereditary Hemorrhagic Telangiectasia. Yang W; Liu A; Hung AL; Braileanu M; Wang JY; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Ahn ES; Huang J Neurosurgery; 2016 May; 78(5):684-93. PubMed ID: 26540357 [TBL] [Abstract][Full Text] [Related]
35. Manifestations of hereditary hemorrhagic telangiectasia in children and adolescents. Folz BJ; Zoll B; Alfke H; Toussaint A; Maier RF; Werner JA Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):53-61. PubMed ID: 15976991 [TBL] [Abstract][Full Text] [Related]
36. Term neonate with intracranial hemorrhage and hereditary hemorrhagic telangiectasia: a case report and review of the literature. Delaney HM; Rooks VJ; Wolfe SQ; Sawyer TL J Perinatol; 2012 Aug; 32(8):642-4. PubMed ID: 22842803 [TBL] [Abstract][Full Text] [Related]
37. Pulmonary Arteriovenous Malformations Are Associated with Silent Brain Infarcts in Hereditary Hemorrhagic Telangiectasia Patients. Brinjikji W; Nasr DM; Wood CP; Iyer VN Cerebrovasc Dis; 2017; 44(3-4):179-185. PubMed ID: 28746925 [TBL] [Abstract][Full Text] [Related]
38. Experience of the Irish National Centre for hereditary haemorrhagic telangiectasia 2003-2008. Ni Bhuachalla CF; O' Connor TM; Murphy M; Colwell N; Brady A Respir Med; 2010 Aug; 104(8):1218-24. PubMed ID: 20362423 [TBL] [Abstract][Full Text] [Related]
39. The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality care. Shovlin CL; Buscarini E; Sabbà C; Mager HJ; Kjeldsen AD; Pagella F; Sure U; Ugolini S; Torring PM; Suppressa P; Rennie C; Post MC; Patel MC; Nielsen TH; Manfredi G; Lenato GM; Lefroy D; Kariholu U; Jones B; Fialla AD; Eker OF; Dupuis O; Droege F; Coote N; Boccardi E; Alsafi A; Alicante S; Dupuis-Girod S Eur J Med Genet; 2022 Jan; 65(1):104370. PubMed ID: 34737116 [TBL] [Abstract][Full Text] [Related]
40. A retrospective cohort study on European Reference Network for Rare Vascular Diseases 5 outcome measures for Hereditary Haemorrhagic Telangiectasia in Denmark. Hvelplund T; Lange B; Bird SD; Korsholm M; Kjeldsen AD Orphanet J Rare Dis; 2022 Jan; 17(1):8. PubMed ID: 34991676 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]